Literature DB >> 8083645

Propagation of JC virus in human neuroblastoma cell line IMR-32.

K Akatani1, M Imai, M Kimura, K Nagashima, N Ikegami.   

Abstract

JC virus (JCV), the causative agent of a human demyelinating disease, progressive multifocal leukoencephalopathy, has a very narrow host range. Cells permissive for infection by JCV have been essentially limited to primary human fetal glial cells, which are difficult to obtain and maintain. In pilot studies, it was found that JCV can multiply in an established cell line of human neuroblastoma. JCV strains Mad-1 and Tokyo-1 were inoculated, respectively, into two cell lines, IMR-32 (neuroblastoma) and A-172 (glioblastoma). Viral infection with cytopathic effect was observed only in IMR-32 cells, and the most efficient viral proliferation was obtained in cells cultured in medium containing 2% fetal calf serum (FCS). Both Mad-1 and Tokyo-1 strains propagated well, with the former being more efficient than the latter. Viral replication was confirmed by immunofluorescence, electron microscopy, and a hemagglutination assay. Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and Western blot analysis of the purified virus revealed the characteristic JCV protein profile. Thus, IMR-32 cells have been found to be permissive for JCV, which should provide a useful system for further studies of virus proliferation and viral tissue tropism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083645     DOI: 10.1002/jmv.1890430104

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  Analysis of capsid formation of human polyomavirus JC (Tokyo-1 strain) by a eukaryotic expression system: splicing of late RNAs, translation and nuclear transport of major capsid protein VP1, and capsid assembly.

Authors:  Y Shishido-Hara; Y Hara; T Larson; K Yasui; K Nagashima; G L Stoner
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Clonal immortalized human glial cell lines support varying levels of JC virus infection due to differences in cellular gene expression.

Authors:  Michael W Ferenczy; Kory R Johnson; Shannon M Steinberg; Leslie J Marshall; Maria Chiara Monaco; Alexander M Beschloss; Peter N Jensen; Eugene O Major
Journal:  J Neuroimmune Pharmacol       Date:  2013-09-20       Impact factor: 4.147

Review 3.  The role of sialic acid in human polyomavirus infections.

Authors:  Gretchen V Gee; Aisling S Dugan; Natia Tsomaia; Dale F Mierke; Walter J Atwood
Journal:  Glycoconj J       Date:  2006-02       Impact factor: 2.916

4.  Distribution and function of JCV agnoprotein.

Authors:  Y Okada; S Endo; H Takahashi; H Sawa; T Umemura; K Nagashima
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

Review 5.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

6.  Major and minor capsid proteins of human polyomavirus JC cooperatively accumulate to nuclear domain 10 for assembly into virions.

Authors:  Yukiko Shishido-Hara; Shizuko Ichinose; Kayoko Higuchi; Yoshinobu Hara; Kotaro Yasui
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

7.  Generation and characterization of JCV permissive hybrid cell lines.

Authors:  Ilker K Sariyer; Mahmut Safak; Jennifer Gordon; Kamel Khalili
Journal:  J Virol Methods       Date:  2009-03-04       Impact factor: 2.014

8.  Comparison of real-time PCR and hemagglutination assay for quantitation of human polyomavirus JC.

Authors:  Moti L Chapagain; Taylor Nguyen; Thomas Bui; Saguna Verma; Vivek R Nerurkar
Journal:  Virol J       Date:  2006-01-09       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.